|
| 阿法骨化醇联合唑来膦酸对骨质疏松症患者骨密度及OPG、BMP-2的影响 |
| The effect of alfacalcidol combined with zoledronic acid on bone mineral density，OPG，and BMP-2 in patients with osteoporosis |
| |
| DOI：10.3969/j.issn.1006-7108.2019.01.017 |
| 中文关键词: 阿法骨化醇 唑来膦酸 骨质疏松 骨密度 |
| 英文关键词:alfacalcidol zoledronic acid osteoporosis bone mineral density |
| 基金项目: |
|
| 摘要点击次数: 1396 |
| 全文下载次数: 560 |
| 中文摘要: |
| 目的 探讨阿法骨化醇联合唑来膦酸的治疗方案对骨质疏松患者骨密度及OPG、BMP-2的影响。方法 将80例骨质疏松患者随机分成联合组和单一治疗组。两组患者均接受常规基础治疗，单一治疗组患者在此基础上接受唑来膦酸治疗，联合治疗组患者接受阿法骨化醇联合唑来膦酸的治疗方案。于治疗前及治疗12个月后评估两组患者的腰椎正位(L2-4)骨密度、股骨颈骨密度、骨保护蛋自(OPG)水平、骨形态发生蛋自-2( BMP-2)水平及治疗效果。结果治疗后，两组患者的腰椎正位(L2-4)骨密度、股骨颈骨密度、OPG及BMP-2均较治疗前有所改变(P<0.01);联合治疗组患者的腰椎正位(L2-4)骨密度及股骨颈骨密度均高于单一治疗组患者(P<0.01);联合治疗组患者的OPG水平高于单一治疗组患者(P<0.01) ;联合治疗组患者的BMP-2水平高于单一治疗组患者(P<0.01);联合治疗组患者的总有效率(97.5 %)高于单一治疗组患者(82.5%) ( P<0.01)。结论 阿法骨化醇联合唑来膦酸在骨质疏松患者中的效果较好，可明显提高患者的骨密度，提高OPG水平，提升BMP-2水平，促进患者的恢复。 |
| 英文摘要: |
| Objective To explore the effect of alfacalcidol combined with zoledronic acid on bone mineral density(BMD)，osteoprotegerin(OPG)，and bone morphogenetic protein-2(BMP-2) in patients with osteoporosis. Methods Eighty patients with osteoporosis were randomly divided into the combined treatment group and the single treatment group. Patients in both groups received conventional basic treatment. Patients in the single treatment group received zoledronic acid treatment, and patients in the combined treatment group received alfacalcidol combined with zoledronic acid treatment. BMD of the lumbar spine(L2-4)and the femoral neck, levels of OPG and BMP-2, and treatment effect were evaluated before and 12 months after treatment. Results After
the treatment, BMD, OPG, and BMP-2 of the patients in both groups were different from those before the treatment(P<0.01).BMD of L2-4 and the femoral neck were higher in the combined treatment group than in the single treatment group(P<0. 01).The OPG level in the combined treatment group was higher than that in the single treatment group(P<0.01).The level of BMP-2 in the combined treatment group was higher than that in the single treatment group(P<0.01).Total effective rate was higher in the combined treatment group(97.5 %)than that in the single treatment group(82.5 %，P<0.0 1).Conclusion Alfacalcidol combined with zoledronic acid has a good effect in patients with osteoporosis，which can significantly improve BMD and the levels of OPG and BMP-2 and promote the recovery of the patients. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |